CORT CIK: 1088856

Corcept Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
361
FY22:
396
FY23:
476
FY24:
664
FY25:
748
(positive)
Change from FY21 to FY25
millions USD
FY21:
124
FY22:
113
FY23:
107
FY24:
137
FY25:
44.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
128
FY22:
116
FY23:
110
FY24:
138
FY25:
46.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
125
FY22:
116
FY23:
125
FY24:
161
FY25:
66.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
113
FY22:
101
FY23:
106
FY24:
141
FY25:
99.7

All amounts in millions USD Data sources:SEC EDGARTwelve Data